SSA
VYGR icon

Schonfeld Strategic Advisors’s Voyager Therapeutics VYGR Stock Holding History

Schonfeld Strategic Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-22,600
Closed -$175K – 2259
2023
Q3 		$175K Sell
22,600
-2,200
-9% -$20.1K ﹤0.01% 1435
2023
Q2 		$284K Buy
+24,800
New +$257K ﹤0.01% 1411
2022
Q4 		– Sell
-19,900
Closed -$117K – 3053
2022
Q3 		$117K Sell
19,900
-7,000
-26% -$44.8K ﹤0.01% 2509
2022
Q2 		$159K Buy
+26,900
New +$182K ﹤0.01% 1979

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Schonfeld Strategic Advisors's VYGR Position: Q4 2023 in Review

Schonfeld Strategic Advisors sold out of Voyager Therapeutics (VYGR) in Q4 2023, closing a stake of 22,600 shares — an estimated $175K sold.

Schonfeld Strategic Advisors first reported a position in VYGR in Q2 2022 and held it in 4 quarters. The position peaked at $284K in Q2 2023. 107 funds tracked by Wall St. Rank hold VYGR as of Q4 2023.

  • Schonfeld Strategic Advisors reported no remaining Voyager Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 22,600 Voyager Therapeutics shares in Q4 2023, an estimated $175K.
  • Schonfeld Strategic Advisors first reported a position in Voyager Therapeutics in Q2 2022 and held it in 4 quarters.
  • Schonfeld Strategic Advisors's Voyager Therapeutics position peaked at $284K in Q2 2023.
  • 107 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.